Other substances

ZINC218242102

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

ZINC218242102 on PubChem

Synonyms

(3S)-3-(3,4-Difluorophenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]-3-(2-hydroxy-4-oxopyrido[1,2-a]pyrimidin-3-yl)propanamide

 

Structure image - ZINC218242102

C1=CC2=NC(=C(C(=O)N2C=C1)[C@@H](CC(=O)NCCC3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)F)F)O

Supporting references

Link Tested on Impact factor Notes Publication date
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
3CLpro Small molecule In silico Screening 		in silico 1.85

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Jul/31/2020
Export (.csv)